Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.6 (
RNA polymerase
)
34,946
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A clofibrate-induced mouse liver cDNA library was prepared and used to isolate the coding sequence for
soluble epoxide hydrolase
. A 1668-base pair (bp) clone was isolated and found to contain a 1269-bp open reading frame coding for 423 amino acids. Subsequent
RNA polymerase
chain reaction resulted in the isolation of 396 bp of additional 5'-sequence. Translation of the resulting 1659-bp open reading frame produced a 553-residue protein (62,527 Da) containing deduced peptide segments that matched the amino acid sequences of six peptide fragments isolated previously from CNBr digests of pure murine
soluble epoxide hydrolase
. Neither the DNA nor the protein sequence showed significant similarity to other currently published sequences. Structural analysis of the
soluble epoxide hydrolase
coding region suggested at least one potential regulatory motif. Expression of the composite cDNA in COS-7 cells resulted in a 5-10-fold increase in
soluble epoxide hydrolase
activity and a similar increase in
soluble epoxide hydrolase
protein amount compared to mock-transfected or vector control-transfected cells. Treatment of C57BL/6J mice with clofibrate led to an approximately 4-fold increase in both
soluble epoxide hydrolase
enzyme activity and steady-state mRNA levels.
...
PMID:Molecular cloning and expression of murine liver soluble epoxide hydrolase. 834 42